Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 120 results for "arm11"

Fundtech launches contactless terminal
Asset Servicing Times

Fundtech Launches New Wireless Card Processing Terminals

NEW YORK, NY The new handheld terminals include a color touch screen and an ARM11 processor, as well as compatibility with the web-based Mobilescape Manager platform. Mobilescape VX provides U.S. businesses with traveling sales personnel the ... Digital Journal, 1 month ago
Fundtech launches contactless terminal Asset Servicing Times, 1 month ago
Fundtech unveils wireless card processing terminal Finextra Research, 1 month ago
[x]  

13 images for arm11

Pink Villa, 5 days ago
Irish Independent, 1 month ago
Reuters, 1 month ago
Manila Bulletin, 1 month ago
PR Web via Yahoo!, 2 months ago
Malaysian Insider, 2 months ago
Yahoo! News, 2 months ago
Reuters India, 2 months ago
The Rakyat Post, 2 months ago
International Business Times Australia, 1 month ago
Bioscience Technology Online

Jacobsen syndrome, autism: Link found

A rare genetic disorder known as Jacobsen syndrome has been linked with autism, according to a recent joint investigation by researchers at San Diego State University and the University of California, San Diego. In addition to suggesting better ...
 Science Daily1 day ago Jacobsen syndrome linked to autism, find UCSD and SDSU researchers  News-Medical.Net2 days ago A link between Jacobsen syndrome and autism  EurekAlert!2 days ago Jacobsen Syndrome, Autism Linked  Bioscience Technology Online4 days ago
[x]  

Football QB Recipient of Weekly Honor

GALESBURG, Illinois A first-year football player who helped lead Knox to its first Lincoln Bowl victory against Eureka College is the winner of a weekly award from the athletic department. Quarterback Matt Mc Caffrey (Wilmette, IL, New Trier) had ...
 Knox College1 week ago

Subspecialty News: Allergan Moving Ahead With DARPin Program

SUBSPECIALTY NEWS SUBSPECIALTY NEWS Company plans a phase 3 trial in wet AMD. BY JERRY HELZNER, SENIOR EDITOR ■ Allergan (Irvine, CA) has reported encouraging progress on its lead DARPin (designed ankyrin repeat proteins) program, the ...
 Retinal Physician1 week ago
Modojo

Looking Back Through Time - The iPhone Over the Years

We're on the cusp of a brand new addition to the iPhone family, and things are about to change within the Apple landscape very soon. What better time to take a look back at the smartphone that could through its various evolutionary stages? The ...
 Modojo1 week ago Why you shouldn't buy an iPhone 3G or iPhone 3GS: iPhone 3G and iPhone 3GS buying advice  PC Advisor1 month ago
ETeknix.com

iGuardian Promises Business-Grade Security for Home Users

0 Flares Twitter 0 Facebook 0 Google+ 0 LinkedIn 0 StumbleUpon 0 Pin It Share 0 Reddit 0 Email ...
 ETeknix.com1 week ago

SYMPLICITY at One Year: Still No BP Benefit vs Controls

BARCELONA, SPAIN — The unblinded one-year results of the SYMPLICITY HTN-3 study, a trial testing the safety and efficacy of renal denervation in patients with resistant hypertension, found there was no difference in office and ambulatory ...
 American Journal of Public Health2 weeks ago
Los Angeles Business

Thanks to $11M, City of Albany supports E. Greenbush casino

Well find out this fall who will get a state license to open a casino in the region. For now, the developers pursuing the $300 million Capital View Casino & Resort in East Greenbush are victorious in one competition: getting the backing of Albany ...
 Los Angeles Business2 weeks ago

The armed citizen deterrent goes to work in Chicago, Toppenish

Investor's Business Daily (IBD) yesterday reported on what appears to be a deterrent effect concealed carry in Illinois that has been followed by lower crime rates in Chicago , and KIRO Eyewitness News reported that the Toppenish School District ...
 Examiner.com2 weeks ago

Cabozantinib (Cometriq) Fails to Meet Primary Endpoint in Pivotal Study of Men With Metastatic Prostate Cancer

Drug currently approved for thyroid cancer Disappointing results have been reported from the final analysis of a pivotal phase III trial of cabozantinib (Cometriq, Exelixis, Inc.) in men with metastatic castration-resistant prostate cancer ...
 PT Community2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less